Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PhenoNet is an AI-powered biotechnology company that specializes in phenotypic drug discovery using high-content imaging and deep learning. Spun out from PhenoVista Biosciences, the company utilizes its proprietary PhenoNet platform to transform complex biological images into actionable data for drug development. By quantifying subtle cellular phenotypes, PhenoNet enables the identification of novel targets and the optimization of lead compounds across various therapeutic areas. The company's approach combines advanced microscopy with state-of-the-art neural networks to accelerate the discovery of first-in-class therapeutics. PhenoNet operates as a platform-driven entity, collaborating with pharmaceutical and biotech partners to enhance their discovery pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PhenoNet.